Home » Archive

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

News, Syndication »

San Diego’s Ambrx Withdraws IPO, Citing Market Conditions

Posted by sandiegobiotech June 30th, 2014 .
No Comments

Ambrx, a San Diego biotech developing antibody-drug conjugates to treat solid tumors and other diseases, said today it is withdrawing its planned IPO because of current market conditions. The company…

[[Click headline to continue reading.]]

More...

News, Syndication »

First appointment in new Salk Fellows Program

Posted by sandiegobiotech June 30th, 2014 .
No Comments

LA JOLLA—The Salk has launched a new initiative called the Salk Fellows Program. The program brings scientists from broad disciplines to the Institute to trigger innovation and perpetuate the collaborative spirit of the Salk.

More...

News, Syndication »

Cidara Therapeutics raises $32 million

Posted by sandiegobiotech June 30th, 2014 .
No Comments

Focused on fungal infections, Cidara has hired local biotech veteran Jeff Stein as CEO.

More...

News, Syndication »

Ambrx Withdraws IPO

Posted by sandiegobiotech June 30th, 2014 .
No Comments

La Jolla-based biotech Ambrx Inc. withdrew its plans for an initial public offering, citing current market conditions, according to Renaissance Capital.

More...

News, Syndication »

Ambrx withdraws IPO

Posted by sandiegobiotech June 30th, 2014 .
No Comments

San Diego biotech company said market conditions caused the IPO cancellation.

More...

News, Syndication »

SDSU reaches for $10 million XPRIZE

Posted by sandiegobiotech June 30th, 2014 .
No Comments

Lambert Ninteman leads student team’s attempt to build a medical tricorder for use by consumers.

More...

News, Syndication »

With $32M, Boston Anti-Fungal Startup Morphs Into San Diego’s Cidara

Posted by sandiegobiotech June 30th, 2014 .
No Comments

Details about the new San Diego biotech headed by former Trius Therapeutics CEO Jeff Stein have been released today. I reported last week on the company’s regulatory filings. The company,…

[[Click headline to continue reading.]]

More...

News, Syndication »

McKerrow Appointed Dean of Skaggs School of Pharmacy and Pharmaceutical Sciences

Posted by sandiegobiotech June 30th, 2014 .
No Comments

Effective July 1, 2014, James H. McKerrow, MD, PhD, will become the second dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. McKerrow will join UC San Diego from UC San Francisc…

More...

News, Syndication »

Saying Nothing With Style: The 2014 BioPharma Edition of BS Bingo

Posted by sandiegobiotech June 30th, 2014 .
No Comments

Several years ago, I wrote an article venting my frustrations with having to sift through the fog and jargon of poorly written analyses of the biotech/pharmaceutical industry. I recounted that,…

[[Click headline to continue reading.]]

More...

News, Syndication »

Study Finds Molecular ‘Yin-Yang’ Regulates Blood Vessel Growth

Posted by sandiegobiotech June 30th, 2014 .
No Comments

The findings from the Yang lab point the way to new anti-cancer strategies.

More...